Recombinant human growth hormone (SMP-140) is effective for growth promotion in hypophysectomized rats

Biomedical Research

Volumn 27, Issue 4, 2006, Pages 191-195

  Nagamine, Jun ^a   Nakagawa, Tsutomu ^a   Taiji, Mutsuo ^a  

^a Drug Research Division   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SMP 140; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; EXPERIMENTAL MODEL; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH PLATE; GROWTH RETARDATION; HORMONE SUBSTITUTION; HYPOPHYSECTOMY; NONHUMAN; RAT; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; GROWTH; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPHYSECTOMY; RATS;

ANIMALIA;

EID: 33748846205     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.27.191     Document Type: Article

References (20)

1. Bangham DR, Gaines Das RE and Schulster D (1985) The international standard for human growth hormone for bioassay: calibration and characterization by international collaborative study. Mol Cell Endocrinol 42, 269-282.
2. Boersma B, Rikken B and Wit JM (1995) Catch-up growth in early treated patients with growth hormone deficiency Dutch Growth Hormone Working Group. Arch Dis Child 72, 427-431.
3. Boersma B and Wit JM (1997) Catch-up growth. Endocr Rev 18, 646-661.
4. Cancedda R, Descalzi-Cancedda F and Castagnola P (1995) Chondrocyte differentiation. Int Rev Cytol 159, 265-358.
5. Damen GM, Boersma B, Wit JM and Heymans HS (1994) Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr 19, 394-400.
6. Drake WM, Howell SJ, Monson JP and Shalet SM (2001) Optimizing GH therapy in adults and children. Endocr Rev 22, 425-450.
7. Gevers EF, van der Eerden BCJ, Karperien M, Raap AK, Robinson ICAF and Wit IM (2002) Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res 17, 1408-1419.
8. Groesbeck MD and Parlow AF (1987) Highly improved precision of the hypophysectomized female rat body weight gain bioassay for growth hormone by increased frequency of injections, avoidance of antibody formation, and other simple modifications. Endocrinology 120, 2582-2590.
9. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423, 332-336.
10. Hering TM (1999) Regulation of chondrocyte gene expression. Front Biosci 4, D743-D761.
11. Isaksson OG, Lindahl A, Nilsson A and Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8, 426-438.
12. Lecointre C and Toublanc JE (1997) Psychological indications for treatment of tall stature in adolescent girls. J Pediatr Endocrinol Metab 10, 529-531.
13. Prader A, Tanner JM and von Harnack G (1963) Catch-up growth following illness or starvation. J Pediatr 62, 646-659.
14. Robson H, Siebler T, Shalet SM and Williams GR (2002) Interactions between GH, IGF-I, glueocorticoids, and thyroid hormones during skeletal growth. Pediatr Res 52, 137-147.
15. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM Hall K, Chatelain PG, Preece MA and Rosenfeld RG (1993) Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 77, 1465-1471.
16. Stevens DA and Williams GR (1999) Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 151, 195-204.
17. Wang J, Zhou J and Bondy CA (1999) Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J 13, 1985-1990.
18. Werther GA, Haynes K, Edmonson S, Oakes S, Buchanan CJ, Herington AC and Waters MJ (1993) Identification of growth hormone receptors on human growth plate chondrocytes. Acta Paediatr 82 suppl 391, 50-53.
19. Woods KA, Camacho-Hubner C, Savage MO and Clark AJL (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335, 1363-1367.
20. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G and Kopchick JJ (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94, 13215-13220.